Trial Profile
A trial to evaluate effectiveness of denosumab in reducing back pain related disability and improving Health Related Quality of Life (HRQoL) in women with postmenopausal osteoporosis and vertebral fractures
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2020
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Calcium carbonate; Colecalciferol
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 18 May 2016 New trial record
- 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases